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Abstract
A 3X RACE technique was used to establish the nucleotide sequence encoding the C-terminal 379 amino acids of rat
intestinal Muc3. Unlike the C-terminus of Muc2 and many secretory mucins, Muc3 contains two EGF motifs and a putative
transmembrane domain. The mRNA for rat Muc3 is 7.5–8.0 kb.
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Reported sequences of cDNAs for mucus glyco-
 .proteins mucins are rarely full-length. This is in part
due to the extraordinarily large size of mucin core
peptides, and their long central stretch of tandem
 .repeats TRs , which make sequencing difficult. TRs
are specific for each mucin, but even for the same
organ, they show little interspecies conservation.
Amino- and carboxyl-end regions tend to show more
interspecies homology. For example, secretory mucins
w x w xsuch as human MUC2 1 , rat Muc 2 2 , porcine
w xsubmaxillary mucin 3 , and frog integumentary mucin
w xFim-B.1 4 , have a similar distribution of cysteine
residues at their C-terminal ends. In two cases, hu-
w xman MUC1 5 and rat mammary sialomucin ASGP2
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w x6 , the C-terminal ends contain a putative transmem-
brane domain and the mucins have been shown bio-
chemically to be membrane-associated.
The amino- and carboxyl-termini of rat Muc2 pre-
. w xviously called MLP have now been sequenced 2,7,8 .
There is a high degree of structural and sequence
homology of rat Muc2 with the human intestinal
mucin MUC2 at its N- and C-terminal ends.
Another rat intestinal cDNA clone called RMUC
w x176 was reported by Gum et al. 9 , and it revealed a
 .tandem repeat structure consensus TTTPDV and a
unique cysteine-containing 92 amino acid sequence at
its C-terminal end. A cDNA clone called M2-798
w xwas also reported by our laboratory 10 and was
found to encode the same consensus TR sequence,
 .but a different not cysteine-enriched unique se-
quence of 82 amino acids at its C-terminal end. Both
rat clones specify different regions of the same gene.
Initially we assumed that this gene might be rat
Muc2, but Northern blots using probes for the TRs
and unique regions of clone M2-798 both hybridized
 .to a transcript 7.5–8.0 kb that was smaller than the
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 .mRNA for rat Muc2 )9.0 kb . We therefore sug-
gested that a second rat intestinal mucin gene existed,
w xand called it M2 10 .
w xComparative chromosomal mapping studies 11
involving human and rodent DNA samples have re-
vealed gene cluster homologies between rat Muc1,
Muc2 and the mucin we called M2, with human
MUC1, MUC2 and MUC3, respectively. This is based
on the conservation of gene synteny for three differ-
ent rat and human chromosomes. The name M2 is
therefore now changed to rat Muc3.
Not surprisingly, there is no homology of the
central tandem repeat regions of human MUC3 and
w xrat Muc3 9 . The C-terminal sequence of human
w xMUC3 has been completed 12 but is not yet pub-
lished, and the comparable region of rat Muc3 has
not been reported. Therefore to provide data with
which to judge possible sequence homologies be-
tween the two mucins, and to initiate functional
studies, rat Muc3 sequencing experiments have been
conducted and are the subject of this report.
Total RNA from rat small intestine was prepared
w x13 , and first strand cDNA synthesis accomplished
 .by reverse transcription RT . The reaction was
 .primed with an Adapter Primer AP and catalyzed
by the Superscript II RNase H-reverse transcriptase
 .both from GIBCO BRL . The target cDNA was
amplified by PCR using two different gene specific
sense primers: primer S1 corresponded to nt 1068–
X  .1089 at the 5 end of the unique non tandem repeat
w xregion of cDNA clone RMUC176 9 , and a nested
primer, S2, corresponded to nt 1320–1341 at the 3X
end of the same cDNA. A dUMP-containing se-
quence was added to the 5X ends of primers S1 and
S2 to facilitate later cloning. The antisense primer
 .UAP BRL also contained a dUMP sequence at the
X  .5 end. PCR utilized Taq polymerase Perkin Elmer
and consisted of denaturation at 948C for 2 min 1
.cycle followed by 30 cycles of denaturation at 948C
for 1 min, annealing and extension at 658C for 1 min,
with a final extension at 728C for 5 min. PCR
products were separated on a 1.5% agarose gel, and
stained with ethidium bromide. The 3X RACE product
using primer S1 was 1.7 kb, while primer S2 the
.nested primer as expected, gave a product 300 bp
shorter. The specific bands were excised from the gel
and purified by genecleaning GenClean II kit, BIO
.101, Vista, CA .
The amplification products were cloned into vector
pAMP1 CLONEAMP pAMP1 system, GIBCO BRL,
.Gaithersburg, MD and transformants confirmed by
DNA sequencing. The 1.7 kb product was sequenced
in both directions using SP6, T7 and subsequent
overlapping primers Biotechnology Services, the
.Hospital for Sick Children, Toronto . The sequence
 .Fig. 1 is 1690 bp long, with the first 273 bp in
complete agreement with the corresponding sequence
 . w xnt 1068–1341 of clone RMUC176 9 . The nested
X  .3 RACE product as expected, was shorter 1470 bp
and matched 100% with the sequence of the 3X RACE
Fig. 1. Nucleotide and deduced amino acid sequence of the 1690
bp 3X RACE product. Nucleotides are numbered on the left,
amino acids on the right. The eight predicted N-glycosylation
sites are marked in bold, and the termination codon is marked
with an asterisk. The putative transmembrane region is under-
lined. The polyadenylation signal AATAAA is in bold italics.
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product at nt position 253–1690. There was a single
open reading frame of 379 amino acids followed by
an untranslated region of 550 nt, which includes the
polyadenylation signal AATAAA, followed closely
by a 37 nt polyA tail.
w xUnlike the tandem repeat region 9,10 , the de-
duced amino acid composition of the C-terminal 379
residues consists of a relatively low content of serine
 .plus threonine 15.5 mol% and a much higher con-
tent of hydrophobic residues 31.8 mol% for com-
.bined leu, ile, met, val, phe, trp, and tyr . Cysteine
comprises 4.49 mol%. Similarity searches of the
 w x.Genbank BLASTP or BLAST program 14 did not
reveal sequence homology nucleic acid or amino
.acid with any other published mucin sequences,
including those for rat Muc2 and human MUC3, or
other proteins.
Using the Wisconsin Sequence Analysis Package
 .Genetic Computer Group, Inc. Madison, Wisconsin ,
 .two EGF epithelial growth factor motifs were iden-
 .tified residues 13–53 and 228–267 , separated by
174 residues. As in many other EGF-containing pro-
teins, the two EGF motifs each contain six cysteines.
The well recognized EGF consensus alignment of
cysteines is not perfectly conserved in the first EGF-
 .like domain residues 13–53 , which implies that this
domain may not be functional. However the second
 .EGF motif residues 228–267 has the same cysteine
and glycine distribution that is particularly well con-
served amongst functional EGF-bearing proteins i.e.
.C-X-X-X-G-FrY-X-G-X-X-C . The existence of
EGF motifs in human intestinal mucin MUC3 has
w xbeen reported in abstract form 12 , but the only other
mucin in which EGF-like sequences EGF1 and
.EGF2 have been published is the ASGP2 membrane
component of the cell surface sialomucin complex
expressed on 13762 rat ascites mammary adeno-
w xcarcinoma cells 6 . ASGP2 has been shown to acti-
vate the EGF receptor kinase from A431 cell mem-
w xbranes and to compete with EGF for binding 15 .
The authors postulate that ASGP2 may act as a
transmembrane growth factor. A potentially interest-
ing observation is that the alignment of the second
EGF motif of rat Muc3 is very close to the EGF2 of
rat ASGP2.
Another interesting feature is that the region 200–
267 contains a total of eight cysteines, as do both
EGF-like domains in ASGP2. Residues 11–53, a
region which includes the first EGF-like region of rat
Muc3, shows seven cysteines, but there is another
cysteine immediately N-terminal to the leucine lo-
 w x.cated at position 1 residue 356 of RMUC176 9 . It
may be reasonable therefore to postulate that the
cysteine-rich regions in these two mucins adopt a
four-loop structure rather than a typical three-loop
EGF domain structure.
The rat Muc3 sequence reveals eight potential
 .N-glycosylation sites Fig. 1 , two potential casein
 .  .kinase CK II sites residues 77 and 152 and two
 .potential protein kinase C PKC phosphorylation
 .sites residues 234 and 271 . Most of these modifica-
tions reside in the first 267 amino acids of the new
C-terminal region. Although PKC has been shown to
be involved in the regulation of mucin secretion from
w x human colonic carcinoma cells 16 , the PKC and
.CK II sites in the C-terminal sequence of rat Muc3
are unlikely to be functional, since they are in the
putative extracellular domain.
w xKyte and Doolittle 17 hydropathy analysis of the
 .deduced 379 residue sequence Fig. 2 reveals a
putative transmembrane domain of 24 amino acids
 .residues 276–299 . Between the transmembrane re-
gion and the stop codon at the C-terminus is a
 .hydrophilic stretch putative cytoplasmic tail of 80
amino acids. These features suggest that rat Muc3,
w xlike the mucins human MUC1 5,18 and rat ASGP2
w x6 , may be a membrane-associated mucin. The 8
amino acid distance from the second EGF-like do-
Fig. 2. Hydrophobicity plot of the 379 amino acid sequence of
Fig. 1. The plot was derived from the algorithm of Kyte and
w xDoolittle 17 using a window of 9 amino acids. Residues 276 to
299 represent the putative transmembrane domain.
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main to the putative transmembrane domain sequence
is essentially the same as that in ASGP2. This rela-
tionship between rat Muc3 and ASGP2 also strength-
ens the argument for rat Muc3 as a new membrane
mucin. Human MUC3 is said to lack a putative
w xtransmembrane region 12 .
Northern blot hybridization analyses were carried
w xout on rat intestinal and colonic RNA 13,19 and a
 .multiple tissue Northern blot CLONTECH contain-
ing RNA from rat heart, brain, spleen, lung, liver,
skeletal muscle, kidney and testis. Probe A was a
 .1-kb cDNA fragment clone M2-1000 described ear-
w xlier 10 , which consists entirely of tandem repeats of
rat Muc3. Probe B consisted of the 3X 1220 bp
 .ECoR1, HindIII fragment nt 275–1494 of the 1.7
kb 3X RACE product presented in Fig. 1. A 1.8-kb
human b-actin cDNA fragment CLONTECH Labo-
.ratories Inc., Palo Alto, CA was used as a control
probe and confirmed that equivalent amounts of each
 .RNA preparation were studied not presented . Probes
w 32 xwere labelled with a- P dCTP using the T7 Quick
 .Prime kit Amersham . Hybridizations were per-
formed at 428C for 18 h with 50% formamide, 5=
SSC, 2% blocking solution Boehringer Manheim
.GmBH, Germany , 0.1% N-lauryl sarcosine, and
0.02% SDS. Blots were washed twice at 658C with
2=SSC and 0.1% SDS for 15 min, exposed to X-ray
film and stored at y708C. Exposure times were 2–3
h for probe A and 2 to 3 days for probe B. Both
probes hybridized to rat intestinal mRNA at a posi-
 .tion of 7.5–8.0 kb Fig. 3 . Another band appeared at
;4 kb, just below the 28S rRNA position. Although
Fig. 3. Northern blots of rat intestinal RNA. Probe A is a tandem
repeat probe for rat Muc3, and probe B is the 3X RACE product
of the present study.
this band may be nonspecific, the possibility of the
existence of two allelic forms of rat Muc3 cannot be
ruled out. The only other tissue RNA to give a signal
 .  .7.5–8.0 kb was rat colon not presented . Prelimi-
nary tests with RNA of human colonic LS174T and
CaCo-2 cells were negative, which probably reflects
the known lack of human MUC3 in LS174T cells,
and a very low level of MUC3 in CaCo-2 cells
w x20–23 . Further cross-hybridization assays and se-
quence comparisons will be necessary to judge ho-
mology of the human and rat genes.
In summary, we have determined the C-terminal
sequence of rat Muc3. Unexpectedly, this intestinal
mucin appears to have features that are more charac-
teristic of a membrane-associated mucin than a true
secretory mucin. The sequence is distinctly different
from the C-terminus of the other known rat intestinal
mucin, rat Muc2.
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